MARIA GUERRERO: Open Payments
NPI 1598829798 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 13 payments from 10 companies in 2025. Trend: 2023 $1,030 · 2024 $976 · 2025 $963
Food & beverage: $864Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $158 |
| AstraZeneca Pharmaceuticals LP | 2 | $157 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $125 |
| PFIZER INC. | 1 | $119 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $92 |
| Neurocrine BioSciences, Inc. | 1 | $85 |
| Janssen Biotech, Inc. | 1 | $37 |
| GENZYME CORPORATION | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $30 |
Products named: CALQUENCE, ZEPZELCA, ZYNLONTA, ADCETRIS, SYLVANT, INGREZZA, MONJUVI, DARZALEX.
Industry payments across TX — which companies pay providers there.
